Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet this
Print
David Hägg
Karolinska Institute, Sweden, Sweden
Poster(s):
(8) Brodalumab Assessment of Hazards: A Multinational Safety (BRAHMS) Study of a Biological Anti-Psoriatic Drug Across Six European Countries
Sunday, August 28, 2022
8:00 AM – 1:45 PM
CEST